HIV Healthcare professional smiling

WELCOME TO
ViiV EXCHANGE
AUSTRALIA

An online portal created to meet the educational needs of Australian based healthcare professionals working in the area of HIV.

We're here until HIV and AIDS are not.

Read more

ViiV HEALTHCARE'S MEDICINES

ViiV Exchange contains the latest information on ViiV Healthcare's medicines to help Australian based healthcare professionals stay up to date on HIV care.

Browse ViiV Healthcare medicines

DOVATO (a fixed dose combination of dolutegravir and lamivudine) is indicated for the treatment of Human Immunodeficiency Virus-1 (HIV-1) infection in adults and adolescents (from 12 years of age weighing at least 40 kg):

  • in antiretroviral treatment-naïve patients with no antiretroviral treatment history who have no known or suspected resistance to either antiretroviral component;
  • or to replace the current antiretroviral regimen in those who are virologically suppressed (HIV-1 RNA less than 50 copies per mL) on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to the integrase inhibitor class or lamivudine.

CABENUVA (cabotegravir prolonged-release suspension for injection and rilpivirine prolonged-release suspension for injection) is indicated for the treatment of HIV-1 in adults who are virologically suppressed (HIV-1 RNA <50 copies per mL) and have no known or suspected resistance to either cabotegravir or rilpivirine.

This medicinal product is subject to additional monitoring in Australia. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse events at www.tga.gov.au/reporting-problems.

ViiV HEALTHCARE'S CLINICAL RESOURCES

VIDEOS AND RECORDINGS

Watch experts in HIV share details of clinical studies and their opinions on the latest data.

 

View videos

CLINICAL AND OTHER RESOURCES

Download conference symposia, webinars, bite-sized infographics and more to help inform your HIV practice.

View resources

PBS Information: These products are listed as Section 100 items. Refer to PBS Schedule for full authority information.

Please review DOVATO and CABENUVA Product Information before prescribing. Full Product Information is available at www.viivhealthcare.com/en-au/our-hiv-medicines/

Using PozQol Digital on a tablet

PozQoL Digital Tool

Access a short, easy-to-use validated tool to measure quality of life among people living with HIV.

View PozQoL Digital Tool

PM-AU-HVX-WCNT-220002. Date of preparation: January 2023.